Shalini is a Senior Research Associate within the Carroll lab.
She has over 10 years of experience in oncology research and drug discovery and was formerly at the University of Cambridge, where she led pre-clinical drug development work using in vivo models of breast and pancreatic cancer on an independent research fellowship. Prior to this Shalini undertook an innovation postdoctoral fellowship funded by the Research Council of Norway exploring the utility and commercial potential of a novel anti-cancer agent. Shalini's areas of expertise include target validation, functional genomics, and the use of advanced in vivo cancer models for the development and testing of novel therapeutics. Her current area of research focuses on establishing sub-type specific interactome maps of Pancreatic and Neuroendocrine Prostate Cancer models with a goal to be able to discover druggable transcription factors.